Added to YB: 2026-10-14
Pitch date: 2026-10-11
MCAP.ST [bullish]
MedCap AB (publ)
+2.42%
current return
Author Info
Slow Compounding is an ex buy-side analyst looking for high-quality companies that create high shareholder returns. Investing for the long-term. Sign up for the newsletter.
Company Info
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
Market Cap
SEK 7.7B
Pitch Price
SEK 517.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.67
P/E
32.06
EV/Sales
3.49
Sector
Health Care Equipment and Supplies
Category
growth
MedCap AB (publ) - $MCAP.ST
MCAP.ST (monitor): MedCap is a strong portfolio candidate: a focused life-science serial acquirer combining organic growth, operational improvement and disciplined M&A. From 2017-2025, EBITA per share compounded at 27.5% with 1.4% average annual dilution, while the EBITA margin rose from 8.3% to 18.4%. Assistive Tech is the main earnings engine and MedTech is improving; key risks are volatile Specialty Pharma earnings, business concentration and maintaining acquisition returns within a narrow target universe.
Read full article (21 min)